Edition:
United States

Cesca Therapeutics Inc (KOOL.OQ)

KOOL.OQ on NASDAQ Stock Exchange Capital Market

0.28USD
17 Aug 2018
Change (% chg)

$0.00 (+1.26%)
Prev Close
$0.28
Open
$0.28
Day's High
$0.28
Day's Low
$0.27
Volume
16,064
Avg. Vol
103,315
52-wk High
$6.43
52-wk Low
$0.26

Latest Key Developments (Source: Significant Developments)

Cesca Therapeutics Q2 Loss Per Share $1.73
Monday, 13 Aug 2018 04:05pm EDT 

Aug 13 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q2 LOSS PER SHARE $1.73.Q2 REVENUE $2.0 MILLION VERSUS $3.5 MILLION.INCURRED IMPAIRMENT CHARGES OF $27.2 MILLION IN QUARTER.  Full Article

Cesca Therapeutics Says Reducing U.S. And India Workforce By About 25 Pct
Monday, 4 Jun 2018 08:30am EDT 

June 4 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS ANNOUNCES REDUCTION IN OPERATING EXPENSES.CESCA THERAPEUTICS INC - REDUCING U.S. AND INDIA WORKFORCE BY ABOUT 25%.CESCA THERAPEUTICS - EXPECTS REDUCTION IN FORCE IN ADDITION TO OTHER COST SAVINGS TO RESULT IN ABOUT $2.5 MILLION IN ANNUALIZED OPERATING EXPENSE SAVINGS.  Full Article

Cesca Therapeutics Reports Q1 Loss Per Share $0.27
Monday, 14 May 2018 04:05pm EDT 

May 14 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q1 LOSS PER SHARE $0.27.Q1 REVENUE $1.9 MILLION VERSUS $3.3 MILLION.  Full Article

Cesca Therapeutics Entered Amendment To Revolving Line Of Credit Facility
Wednesday, 18 Apr 2018 06:17am EDT 

April 18 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS SAYS ON APRIL 16, ENTERED AMENDMENT TO ITS REVOLVING LINE OF CREDIT FACILITY - SEC FILING.CESCA THERAPEUTICS - WITH AMENDED CREDIT AGREEMENT, ON APRIL 16, CO ENTERED INTO FIRST AMENDED AND RESTATED NOMINATION AND VOTING AGREEMENT.CESCA THERAPEUTICS - AMENDED NOMINATION AGREEMENT WILL TERMINATE ACCORDING TO ITS TERMS WHEN AND IF THE BOYALIFE OWNERSHIP PERCENTAGE FALLS BELOW 20%.  Full Article

Cesca Therapeutics Announces Release Of X-Mini Cell Selection Kit
Tuesday, 3 Apr 2018 08:30am EDT 

April 3 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS INC. ANNOUNCES RELEASE OF X-MINI CELL SELECTION KIT FOR THE CAR-T RESEARCH MARKET.  Full Article

Cesca Therapeutics Announces Pricing Of Public Offering
Wednesday, 29 Nov 2017 09:07am EST 

Nov 29 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF UP TO 900,000 SHARES OF COMMON STOCK.CESCA THERAPEUTICS INC - PRICED REGISTERED PUBLIC OFFERING AT $3.00 PER SHARE​.  Full Article

Cesca Therapeutics Announces Proposed Public Offering Of Common Stock
Tuesday, 28 Nov 2017 05:20pm EST 

Nov 28 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.  Full Article

Cesca Therapeutics reports quarterly loss per share $0.24
Tuesday, 14 Nov 2017 04:05pm EST 

Nov 14 (Reuters) - Cesca Therapeutics Inc ::Cesca Therapeutics announces financial results for the three months ended September 30, 2017 and provides corporate update.Quarterly loss per share $0.24.Quarterly revenue $3.1 million versus $3.8 million.  Full Article

Cesca Therapeutics ‍receives Notice of Allowance for U.S. patent application covering a novel method of cell separation​
Tuesday, 3 Oct 2017 07:00am EDT 

Oct 3 (Reuters) - Cesca Therapeutics Inc : :Cesca Therapeutics Inc - ‍receives Notice of Allowance for U.S. patent application covering a novel method of cell separation​.  Full Article

Cesca Therapeutics says co entered into Amendment No. 1 to Revolving Credit Agreement with Boyalife Investment Fund II​
Friday, 22 Sep 2017 06:52am EDT 

Sept 22 (Reuters) - Cesca Therapeutics Inc :Cesca Therapeutics - ‍on September 13, 2017, co entered into an Amendment No. 1 to Revolving Credit Agreement with Boyalife Investment Fund II, Inc​.Cesca Therapeutics - amendedment amends Revolving Credit Agreement entered on March 6, 2017, by increasing borrowing availability to $10.0 million​.Cesca Therapeutics - ‍in connection with amendment, co entered amended and restated convertible promissory note to reflect new amount of $10.0 million​.  Full Article

BRIEF-Cesca Prices $5.5 Million Public Offering

* CESCA THERAPEUTICS INC - IS OFFERING UNITS AT A PRICE OF $0.60 PER UNIT.